Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine

pharmaceutical-technologyAugust 12, 2021

Tag: AzurRx , FW-1022 , COVID-19 , RESERVOIR

PharmaSources Customer Service